Gene expression programmes that are induced by inflammatory or oncogenic signals are controlled by shared chromatin regulators. Such chromatin dependencies are known to regulate oncogenes and inflammation-promoting genes and can be leveraged to combine and increase the effectiveness of immune-cell-based therapies with epigenetic therapies.
- Ivan Marazzi
- Benjamin D. Greenbaum
- Ernesto Guccione